Acrospire Investment Management LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$28,000
-89.4%
3,014
-90.1%
0.02%
-78.9%
Q4 2016$264,000
+438.8%
30,513
+291.2%
0.11%
+230.3%
Q3 2016$49,000–7,800–0.03%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2017.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders